ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 191 filers reported holding ASCENDIS PHARMA A/S in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $39,277 | -10.1% | 288 | -0.3% | 0.00% | 0.0% |
| Q1 2024 | $43,688 | +20.4% | 289 | +0.3% | 0.00% | 0.0% |
| Q4 2023 | $36,274 | +36.9% | 288 | +1.8% | 0.00% | +33.3% |
| Q3 2023 | $26,500 | -0.0% | 283 | -4.7% | 0.00% | 0.0% |
| Q2 2023 | $26,507 | -45.5% | 297 | -34.6% | 0.00% | -50.0% |
| Q1 2023 | $48,678 | -25.4% | 454 | -15.0% | 0.01% | -25.0% |
| Q4 2022 | $65,217 | +27.9% | 534 | +8.8% | 0.01% | -11.1% |
| Q3 2022 | $51,000 | +6.2% | 491 | -4.3% | 0.01% | +12.5% |
| Q2 2022 | $48,000 | +2.1% | 513 | +29.2% | 0.01% | +14.3% |
| Q1 2022 | $47,000 | -13.0% | 397 | -0.3% | 0.01% | -12.5% |
| Q4 2021 | $54,000 | -35.7% | 398 | -24.2% | 0.01% | -63.6% |
| Q3 2021 | $84,000 | +18.3% | 525 | -2.2% | 0.02% | +37.5% |
| Q2 2021 | $71,000 | +24.6% | 537 | +22.0% | 0.02% | +23.1% |
| Q1 2021 | $57,000 | -17.4% | 440 | +6.8% | 0.01% | -23.5% |
| Q4 2020 | $69,000 | +9.5% | 412 | +0.7% | 0.02% | 0.0% |
| Q3 2020 | $63,000 | +37.0% | 409 | +31.9% | 0.02% | +21.4% |
| Q2 2020 | $46,000 | 0.0% | 310 | -24.4% | 0.01% | -17.6% |
| Q1 2020 | $46,000 | -65.2% | 410 | -56.9% | 0.02% | -63.0% |
| Q4 2019 | $132,000 | +61.0% | 952 | +11.7% | 0.05% | +48.4% |
| Q3 2019 | $82,000 | +54.7% | 852 | +83.2% | 0.03% | +55.0% |
| Q2 2019 | $53,000 | -32.1% | 465 | -30.1% | 0.02% | -35.5% |
| Q1 2019 | $78,000 | +44.4% | 665 | -23.1% | 0.03% | +14.8% |
| Q4 2018 | $54,000 | – | 865 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 2,003,147 | $225,574,000 | 20.44% |
| RA Capital Management | 4,914,955 | $553,473,000 | 17.48% |
| Sofinnova Investments, Inc. | 1,109,874 | $124,983,000 | 11.56% |
| Eversept Partners, LP | 275,494 | $31,023,379 | 7.71% |
| Avoro Capital Advisors LLC | 1,787,000 | $201,234,000 | 6.79% |
| Orbimed Advisors | 3,287,400 | $370,194,000 | 6.22% |
| Eventide Asset Management | 1,698,648 | $191,285,000 | 6.19% |
| Logos Global Management LP | 120,000 | $13,513,000 | 5.14% |
| Ghost Tree Capital, LLC | 150,000 | $16,892,000 | 4.48% |
| Spyglass Capital Management LLC | 351,388 | $39,570,000 | 4.47% |